NCT00029874View on ClinicalTrials.gov

Minocycline in Patients With Huntington's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

August 31, 2003

Conditions
Huntington's Disease
Interventions
DRUG

Minocycline

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00029874 - Minocycline in Patients With Huntington's Disease | Biotech Hunter | Biotech Hunter